Tesamorelin is a synthetic GHRH analog approved for reducing visceral adipose tissue in HIV‑associated lipodystrophy.
Benefits
- Growth Hormone Stimulation: Enhances endogenous GH release.
- Visceral Fat Reduction: Clinically proven to reduce abdominal fat.
- Potential Longevity Research: Studied for anti‑aging and metabolic benefits.
- Muscle Preservation: Supports lean body mass retention.
Applications
- Research into lipodystrophy management.
- Studies on body composition and muscle preservation.
- Exploration of GH modulation in aging research.
Consumption & Measurements
- Administered via daily subcutaneous injection.
- Measurements include IGF‑1 levels, visceral fat scans, and lean muscle mass.
- Research protocols monitor lipid metabolism and GH secretion profiles.
